Clinical outcome and safety profile of rituximab for the treatment of Dipeptidyl peptidase 4 inhibitors-induced Bullous pemphigoid

  1. Nieto-Benito, L.M.
  2. Bergón-Sendín, M.
  3. Pulido-Pérez, A.
  4. Suárez-Fernández, R.M.
Journal:
Experimental Dermatology

ISSN: 1600-0625,  0906-6705

Year of publication: 2022

Volume: 31

Issue: 4

Pages: 641-642

Type: Letter

DOI: 10.1111/EXD.14483 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus